C215 - Peripheral Neuropathy II: Update on Diabetic, Immune Axonal, and Hematologic-related Neuropathies
| Event Time: | Thursday May 9, 2019 1:00 pm to 3:00 pm |
| Topic(s): | Neuromuscular and Clinical Neurophysiology (EMG), Foundations in Clinical Neurology for APPs |
| Director(s): | Michelle Mauermann MD, FAAN |
| Description: | Peripheral neuropathies are common and affect almost eight percent of the population over age 55. New diagnostic and management options make rational therapies for PN increasingly possible. The high cost of certain diagnostic tests and therapies, along with the complexities involved in choosing which tests and treatments to initiate, complicate the management of patients with PN. Faculty will provide an update on diagnosis and management of diabetic neuropathies, immune axonal neuropathies, and neuropathies associated with hematologic disorders, including ATTR amyloidosis. This program complements Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies and Peripheral Neuropathy III: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives, but covers independent topics. |
| Completion Message: | Participants should be able to identify the distinct forms of diabetic neuropathy; determine whether a neuropathy is likely to be related to diabetes; and obtain a rational, evidence-based approach to treating diabetic neuropathies. Participants should become familiar with the differential diagnosis and work-up of axonal neuropathies and use a rational, evidence-based approach to treat immune axonal neuropathies. Participants should become familiar with the relevance of monoclonal gammopathies in relationship to peripheral neuropathy; recognize the presentations of neurolymphoma; and get an update on new break-throughs in the field of ATTR amyloidosis. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge |
| Start/End Time | Title | Faculty |
|---|---|---|
| 1:00 PM - 1:05 PM | Introduction | Michelle L. Mauermann MD, FAAN |
| 1:05 PM - 1:40 PM | Update in Diabetic Neuropathies | Brian Callaghan MD, FAAN |
| 1:40 PM - 2:15 PM | Update in Immune Axonal Neuropathies | Chafic Y. Karam MD |
| 2:15 PM - 2:50 PM | Update in Hematologic-related Neuropathies and hATTR Amyloidosis | Michelle L. Mauermann MD, FAAN |
| 2:50 PM - 3:00 PM | Discussion/Questions and Answers | Faculty |
| Speaker | Disclosure |
|---|---|
| Brian Callaghan, MD, FAAN | Dr. Callaghan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with DynaMed. Dr. Callaghan has received personal compensation in an editorial capacity for American Academy of Neuroloy. |
| Chafic Y. Karam, MD | Dr. Karam has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Akcea, Alexion, Alnyalm, Biogen, CSL Behring, Cytokinetics, Genzyme, Guidepoint, GLG. Dr. Karam has received research support from Genzyme. |
| Michelle L. Mauermann, MD, FAAN | Dr. Mauermann has received research support from Research support from IONIS and Alnylam.. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C243 -
Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis
Michael Weiss MD, FAAN |
|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
| 9:15 AM-11:30 AM |
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 1:00 PM-3:00 PM |
|
S58 -
Therapeutics in Neuromuscular Disorders
|
| 2:00 PM-2:45 PM |
|
Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1
Nicholas Johnson MD, FAAN |
|
Consensus-Based Care Recommendations for Adults with haha
|